This is one of the results indicated by the latest report of the ‘Global Tobacco Industry Interference Index’ published this November and in which Spain obtains a score that places it behind 35 countries out of the 57 analyzed.
The results show that this type of surgery can represent a good option for people affected by this syndrome since it supposes a reduction in the incidence of cancer and its mortality.
The correct classification of genetic variants can help in the early diagnosis and personalized treatment of cancer in patients who carry this gene.
Not all video games are the same in terms of addictive potential, nor all patterns of behavior can be considered risky. But the scientific community agrees, and also among some regulators, is that the so-called “reward boxes”, or loot boxes, seem to be on the border between video games and gambling.
The close relationship between gambling and video games Read More »
The team of Dr. Eva González-Suarez, from the CNIO and IDIBELL, and the team of Dr. Christos Sotiriou, from the Jules Bordet Institute, demonstrate that a drug already used to treat osteoporosis promotes the infiltration of immune cells in breast tumors.
With this project, Dr. M Carolina Florian, from the IDIBELL’s Regenerative Medicine Program, aims to improve the survival and quality of life of elderly patients undergoing chemotherapy.
The most innovative technology projects in the healthcare sector were presented this November 26th at the third edition of the Accelerator Meeting Point (AMP). The digital meeting allowed different IDIBELL entrepreneurs and invited entities from the HealthTech/Biotech sector to espouse their projects to investors and pharmaceutical companies to obtain financing.
IDIBELL has held a meeting with the best Healthtech projects Read More »
IDIBELL has been one of the institutions with more funded projects, up to 10, of which it leads 7, and participates in 3 more projects as a collaborator.
La Marató will finance with 1.5 million euros 10 IDIBELL projects in rare diseases Read More »
Next Saturday, November 28th, researchers of Bellvitge will present their most recent investigations to the general public. The new website Sinergia will broadcast a wide program of virtual talks. Sinergia has been specifically released to celebrate the first virtual edition of the Festival for the Research and Innovation in Health of L’Hospitalet.
New biomedical breakthroughs of Bellvitge, live streaming on November 28th Read More »
A total of 44 researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and Bellvitge University Hospital (HUB) sign an article in the International Journal of Infectious Diseases, where they demonstrate the beneficial effect of the use of corticosteroids added to tocilizumab treatment to improve the prognosis of critical patients of Covid-19.
